4,5 caffeoylquinic acid and scutellarin, identified by integrated metabolomics and proteomics approach as the active ingredients of Dengzhan Shengmai, act against chronic cerebral hypoperfusion by regulating glutamatergic and GABAergic synapses
Ning Sheng, Hao Zheng, Min Li, Menglin Li, Zhe Wang, Ying Peng, Haibo Yu, Jinlan Zhang
Topics & Concepts
GlutamatergicGlutamate receptorGABAergicPharmacologyChemistryExcitatory postsynaptic potentialNeuroscienceBiologyInhibitory postsynaptic potentialBiochemistryReceptorNeurological Disease Mechanisms and TreatmentsTraditional Chinese Medicine AnalysisFlavonoids in Medical Research